Scientific Review of Tamoxifen
Status: Listed in the Report on Carcinogens (RoC)
Primary Uses or Exposures: Tamoxifen is used as an anti-estrogen drug in the palliative treatment of breast cancer and to reduce the incidence of breast cancer in women at high risk of this disease.
- Appendix A: Excerpts from the IARC Monograph on the Evaluation of the Carcinogenic Risks of Chemicals to Humans Volume 66 (Some Pharmaceutical Drugs) Tamoxifen, pp. 253-365, 1996.
- NTP Board of Scientific Counselors RoC Subcommittee Meeting (October 30–31, 1997)
Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, email us or use our contact form and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.